EquityZen Growth Technology Fund LLC - Series 1985
Raised
$110K
Investors
8
Min Invest
$9,996
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1985 is a Delaware pooled investment fund filed by EquityZen Advisors and Phil Haslett, raising $110K from 8 investors with a $10K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This is part of the EquityZen platform, which operates 1,889 related entities specializing in pre-IPO secondary market access through individual series vehicles.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption structure typical of EquityZen's series vehicle model. The $10K minimum investment represents the retail-accessible tier common across the platform's offerings, enabling fractional exposure to private company equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
